Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)
Titel:
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)
Auteur:
Chounta, Vasiliki Overton, Edgar T. Mills, Anthony Swindells, Susan Benn, Paul D. Vanveggel, Simon van Solingen-Ristea, Rodica Wang, Yuanyuan Hudson, Krischan J. Shaefer, Mark S. Margolis, David A. Smith, Kimberly Y. Spreen, William R.